CannaPharmaRx Inc logo

CPMD - CannaPharmaRx Inc Share Price

$1.01 0.0  1.0%

Last Trade - 02/07/20

Sector
Healthcare
Size
Micro Cap
Market Cap £30.0m
Enterprise Value £37.1m
Revenue £n/a
Position in Universe 4852nd / 6344
Bullish
Bearish
Unlock CPMD Revenue
Momentum
Relative Strength (%)
1m -30.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -66.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Cannapharmarx Inc revenues was not reported. Net loss increased from $1.1M to $4.2M. Higher net loss reflects Acquisition expenses increase from $26K to $1.9M (expense), Interest Expense increase from $122K to $719K (expense), Stock based compensation increase of 28% to $207K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.05 to -$0.12.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CPMD Revenue Unlock CPMD Revenue

Net Income

CPMD Net Income Unlock CPMD Revenue

Normalised EPS

CPMD Normalised EPS Unlock CPMD Revenue

PE Ratio Range

CPMD PE Ratio Range Unlock CPMD Revenue

Dividend Yield Range

CPMD Dividend Yield Range Unlock CPMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CPMD EPS Forecasts Unlock CPMD Revenue
Profile Summary

CannaPharmaRx, Inc. is a pharmaceutical company. The Company focuses on advancing cannabinoid research and discovery using formulation and drug delivery technology under development. The Company also focuses on owning and operating compounding and specialty pharmacies. It focuses on prescription, personal care/nutraceutical, and animal health cannabinoid-based products to market in the United States and across the world. It intends to serve the marketplace for drug products in various therapeutic categories, including schizophrenia and other psychotic disorders, oncology, infectious disease, pain management, multiple sclerosis, inflammatory disease, gastrointestinal disorders and ophthalmology. It intends to develop both single and combination prescription entity products by conducting animal and human Phase I to Phase V clinical trials. It intends to identify, analyze and recommend the appropriate use of cannabinoid molecules in combination with various pharmaceutical products.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated December 17, 2010
Public Since October 29, 1999
No. of Shareholders: 293
No. of Employees: 4
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OTC Markets Group
Shares in Issue 37,115,939
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CPMD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CPMD
Upcoming Events for CPMD
Frequently Asked Questions for CannaPharmaRx Inc
What is the CannaPharmaRx Inc share price?

As of 02/07/20, shares in CannaPharmaRx Inc are trading at $1.01, giving the company a market capitalisation of £30.0m. This share price information is delayed by 15 minutes.

How has the CannaPharmaRx Inc share price performed this year?

Shares in CannaPharmaRx Inc are currently trading at $1.01 and the price has moved by -44.51% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CannaPharmaRx Inc price has moved by -44.34% over the past year.

What are the analyst and broker recommendations for CannaPharmaRx Inc?

There are no analysts currently covering CannaPharmaRx Inc.

When will CannaPharmaRx Inc next release its financial results?

CannaPharmaRx Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the CannaPharmaRx Inc dividend yield?

CannaPharmaRx Inc does not currently pay a dividend.

Does CannaPharmaRx Inc pay a dividend?

CannaPharmaRx Inc does not currently pay a dividend.

When does CannaPharmaRx Inc next pay dividends?

CannaPharmaRx Inc does not currently pay a dividend.

How do I buy CannaPharmaRx Inc shares?

To buy shares in CannaPharmaRx Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CannaPharmaRx Inc?

Shares in CannaPharmaRx Inc are currently trading at $1.01, giving the company a market capitalisation of £30.0m.

Where are CannaPharmaRx Inc shares listed? Where are CannaPharmaRx Inc shares listed?

Here are the trading details for CannaPharmaRx Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: CPMD
What kind of share is CannaPharmaRx Inc?

Based on an overall assessment of its quality, value and momentum, CannaPharmaRx Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CannaPharmaRx Inc share price forecast 2020?

We were not able to load any forecast data for CannaPharmaRx Inc.

How can I tell whether the CannaPharmaRx Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CannaPharmaRx Inc. Over the past six months, the relative strength of its shares against the market has been -14.06%. At the current price of $1.01, shares in CannaPharmaRx Inc are trading at -32.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CannaPharmaRx Inc PE Ratio?

We were not able to find PE ratio data for CannaPharmaRx Inc.

Who are the key directors of CannaPharmaRx Inc?

CannaPharmaRx Inc's management team is headed by:

Dominick Colvin - CHM
Matthew Nicosia - DRC
James Samuelson - PRE
Marc Branson - DRC
Richard Orman - DRC
Andrew Steedman - EVP
John Cassels - CFO
Who are the major shareholders of CannaPharmaRx Inc?

Here are the top five shareholders of CannaPharmaRx Inc based on the size of their shareholding:

Colvin (Dominic) Individual Investor
Percentage owned: 19.07% (6.99m shares)
Steedman (Andrew) Individual Investor
Percentage owned: 0.01% (4.00k shares)
Similar to CPMD
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.